Table 3.
Timeline | Monitoring | Action Plan |
---|---|---|
Prenatal counseling | ● Blood pressure check ● SLE clinical assessments ● Routine labs* with addition of anti-Ro/SSA, anti-La/SSB, antiphospholipid antibodies, lupus anticoagulant |
● If pregnancy is not desired, discuss effective birth control options ● For those desiring pregnancy: o Switch to pregnancy compatible medications o Ensure low disease activity or remission at least 6 months o Discontinue NSAIDS in those having difficulties conceiving o Start on or continue with HCQ if not contraindicated |
First Trimester | ● Blood pressure check ● SLE clinical assessment ● Labs* ● Fetal ultrasound to ensure intrauterine pregnancy and establish gestational age |
● Start Aspirin 81 mg/day ● Be vigilant for disease flares ● Review medication adherence ● Patients with OB-APS should start prophylactic heparin ● Patients with thrombotic APS should start full dose heparin ● for active SLE disease, increase or add pregnancy compatible DMARD |
Second Trimester | ● Blood pressure check ● SLE clinical assessment ● Labs* with assessment for gestational diabetes and genetic screening (if applicable) ● Fetal ECHO starting at week 16 through week 25 for mothers with +anti-Ro/SSA or +anti-La/SSB ● Ultrasound to evaluate fetal anatomy and to assess fetal growth, placental insufficiency |
● Be vigilant for disease flares ● Review medication adherence ● In fetuses with evidence for 1st or 2nd degree heart block, start oral dexamethasone 4 mg daily for several weeks then assess response ● For fetuses with 3rd degree heart block without cardiac inflammation, avoid dexamethasone ● Avoid NSAIDS at 20 weeks and beyond. |
Third Trimester | ● Blood pressure check ● SLE clinical assessment ● Labs* ● Ultrasound regularly to evaluate fetal growth, adequacy of amniotic fluid, placental insufficiency |
● Be vigilant for disease flares ● Review medication adherence ● Review preparations for labor and delivery |
Post-partum and Lactation | ● Blood pressure check ● SLE clinical assessment ● Labs* |
● Be vigilant for disease flares ● Switch to lactation compatible medications if breastfeeding is desired ● For prednisone ≥20 mg/day, avoid breastfeeding 4 hours after dosing |
Notes: *Labs to be included: complete blood count (CBC), comprehensive metabolic profile (CMP), urinalysis and morning urine protein to creatinine ratio (UPCR), anti-double stranded DNA (dsDNA) antibodies, complement levels (CH50, or C3 and C4), serum uric acid.
Abbreviations: SLE, systemic lupus erythematosus; HCQ, hydroxychloroquine; NSAIDS, nonsteroidal anti-inflammatory drugs; OB-APS, obstetric antiphospholipid syndrome; DMARD, disease modifying antirheumatic drug; ECHO, echocardiogram.